Lexicon Pharmaceuticals, Inc (LXRX) insider trading
Every open-market stock purchase and sale by Lexicon Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $2.7M over the last 12 months (5 buys).
- Last insider buy: Raymond Debbane (Director), $3K, 7 months ago.
Last 12 months: insiders bought $2.7M (5 buys) and sold $0 (0 sales). Last close $1.91 on Jun 4, 2026.
Recent LXRX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 3, 2026 | Raymond Debbane (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Philippe Amouyal (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Judith L Swain (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Christopher J Sobecki (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Ivan Cheung (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Diane E. Sullivan (Director) | Bought (not open market) | — |
| Jun 3, 2026 | Sam L Barker (Director) | Bought (not open market) | — |
| May 1, 2026 | Judith L Swain (Director) | Bought (not open market) | — |
| May 1, 2026 | Philippe Amouyal (Director) | Bought (not open market) | — |
| May 1, 2026 | Judith L Swain (Director) | Bought (not open market) | — |
| May 1, 2026 | Sam L Barker (Director) | Bought (not open market) | — |
| May 1, 2026 | Christopher J Sobecki (Director) | Bought (not open market) | — |
| May 1, 2026 | Ivan Cheung (Director) | Bought (not open market) | — |
| May 1, 2026 | Diane E. Sullivan (Director) | Bought (not open market) | — |
| May 1, 2026 | Ivan Cheung (Director) | Bought (not open market) | — |
| May 1, 2026 | Raymond Debbane (Director) | Bought (not open market) | — |
| May 1, 2026 | Christopher J Sobecki (Director) | Bought (not open market) | — |
| May 1, 2026 | Raymond Debbane (Director) | Bought (not open market) | — |
| May 1, 2026 | Philippe Amouyal (Director) | Bought (not open market) | — |
| May 1, 2026 | Diane E. Sullivan (Director) | Bought (not open market) | — |
| May 1, 2026 | Sam L Barker (Director) | Bought (not open market) | — |
| Apr 30, 2026 | Participations S.a r.l. Artal (Insider) | Bought (not open market) | — |
| Apr 30, 2026 | Participations S.a r.l. Artal (Insider) | Bought (not open market) | — |
| Apr 30, 2026 | Participations S.a r.l. Artal (Insider) | Bought (not open market) | — |
| Feb 28, 2026 | Michael Exton (CEO) | Sold (not open market) | $301K |
Who's trading LXRX
- Philippe Amouyal, Director: other filings, last Jun 3, 2026
- Christopher J Sobecki, Director: other filings, last Jun 3, 2026
- Raymond Debbane, Director: bought $723K (7 buys), last Jun 3, 2026
- Diane E. Sullivan, Director: other filings, last Jun 3, 2026
- Sam L Barker, Director: other filings, last Jun 3, 2026
- Judith L Swain, Director: other filings, last Jun 3, 2026
- Ivan Cheung, Director: other filings, last Jun 3, 2026
- Participations S.a r.l. Artal, Insider: other filings, last Apr 30, 2026
- Rachel Yap Martens, VP: other filings, last Feb 28, 2026
- Scott M Coiante, CFO: other filings, last Feb 28, 2026
- Brian T Crum, VP: other filings, last Feb 28, 2026
- Lisa DeFrancesco, VP: other filings, last Feb 28, 2026
- Michael Exton, CEO: other filings, last Feb 28, 2026
- Suma Gopinathan, VP: other filings, last Feb 28, 2026
- Craig B Granowitz, C-suite exec: other filings, last Feb 28, 2026
Get free alerts when an insider at Lexicon Pharmaceuticals, Inc files a new trade →